Saad, F., Winquist, E., Hubay, S., Berry, S., Assi, H., Levesque, E., Aucoin, N., Czaykowski, P., Lattouf, J.-B., Alloul, K., Stewart, J. and Sridhar, S.S. 2016. Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. Canadian Urological Association Journal. 10, 3-4 (Apr. 2016), 102–9. DOI:https://doi.org/10.5489/cuaj.3470.